Omnicell Gross Margin 2010-2024 | OMCL

Current and historical gross margin for Omnicell (OMCL) over the last 10 years. The current gross profit margin for Omnicell as of September 30, 2024 is %.
Omnicell Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $1.06B $0.43B 40.79%
2024-06-30 $1.08B $0.44B 41.07%
2024-03-31 $1.10B $0.46B 42.07%
2023-12-31 $1.15B $0.50B 43.21%
2023-09-30 $1.19B $0.51B 43.22%
2023-06-30 $1.24B $0.54B 43.69%
2023-03-31 $1.27B $0.56B 44.48%
2022-12-31 $1.30B $0.59B 45.45%
2022-09-30 $1.31B $0.62B 47.06%
2022-06-30 $1.26B $0.60B 48.05%
2022-03-31 $1.20B $0.58B 48.54%
2021-12-31 $1.13B $0.55B 48.94%
2021-09-30 $1.07B $0.53B 49.44%
2021-06-30 $0.99B $0.48B 48.48%
2021-03-31 $0.92B $0.43B 46.56%
2020-12-31 $0.89B $0.41B 46.36%
2020-09-30 $0.89B $0.41B 46.41%
2020-06-30 $0.91B $0.43B 47.30%
2020-03-31 $0.92B $0.45B 48.70%
2019-12-31 $0.90B $0.44B 48.72%
2019-09-30 $0.86B $0.42B 48.20%
2019-06-30 $0.84B $0.40B 48.09%
2019-03-31 $0.81B $0.39B 47.90%
2018-12-31 $0.79B $0.37B 47.21%
2018-09-30 $0.77B $0.36B 47.02%
2018-06-30 $0.76B $0.35B 46.23%
2018-03-31 $0.75B $0.34B 45.25%
2017-12-31 $0.71B $0.32B 44.60%
2017-09-30 $0.69B $0.30B 43.79%
2017-06-30 $0.68B $0.30B 43.99%
2017-03-31 $0.67B $0.30B 44.51%
2016-12-31 $0.70B $0.32B 45.69%
2016-09-30 $0.65B $0.31B 46.85%
2016-06-30 $0.60B $0.29B 47.91%
2016-03-31 $0.54B $0.27B 49.35%
2015-12-31 $0.48B $0.25B 51.24%
2015-09-30 $0.48B $0.25B 51.89%
2015-06-30 $0.46B $0.24B 52.37%
2015-03-31 $0.46B $0.24B 53.07%
2014-12-31 $0.44B $0.23B 52.94%
2014-09-30 $0.43B $0.23B 53.29%
2014-06-30 $0.41B $0.22B 53.81%
2014-03-31 $0.40B $0.21B 53.54%
2013-12-31 $0.38B $0.20B 53.28%
2013-09-30 $0.37B $0.20B 53.42%
2013-06-30 $0.36B $0.19B 53.24%
2013-03-31 $0.34B $0.18B 53.27%
2012-12-31 $0.31B $0.17B 54.31%
2012-09-30 $0.29B $0.16B 54.90%
2012-06-30 $0.27B $0.15B 54.51%
2012-03-31 $0.25B $0.14B 55.56%
2011-12-31 $0.25B $0.14B 55.51%
2011-09-30 $0.24B $0.13B 54.81%
2011-06-30 $0.23B $0.13B 54.98%
2011-03-31 $0.23B $0.12B 54.22%
2010-12-31 $0.22B $0.12B 53.15%
2010-09-30 $0.22B $0.11B 51.82%
2010-06-30 $0.22B $0.11B 50.92%
2010-03-31 $0.22B $0.11B 50.46%
2009-12-31 $0.21B $0.11B 49.07%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.964B $1.147B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00